Tirzepatide works as a dual GLP-1 agonist and GIP agonist to maximize similar benefits that are seen with GLP-1 medications such as semaglutide. It is currently implemented as a second-line diabetes medication, similar to GLP-1 medications, and has been used for obesity treatment.

• 180 sprays, each spray is 28MCG of Tirzepatide.
• Bottle = 30ml

For research purposes only:

7 sprays daily

THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. These statements, products have not been evaluated by the FDA, These products are not intended to diagnose treat prevent or cure any disease. Research Chemicals ARE NOT FOR HUMAN CONSUMPTION